@article {Salphati1301, author = {Laurent Salphati and Xiaoyan Chu and Liangfu Chen and Bhagwat Prasad and Shannon Dallas and Raymond Evers and Donna Mamaril-Fishman and Ethan G. Geier and Jonathan Kehler and Jeevan Kunta and Mario Mezler and Loic Laplanche and Jodie Pang and Anja Rode and Matthew G. Soars and Jashvant D. Unadkat and Robert A. B. van Waterschoot and Jocelyn Yabut and Alfred H. Schinkel and Nico Scheer}, title = {Evaluation of Organic Anion Transporting Polypeptide 1B1 and 1B3 Humanized Mice as a Translational Model to Study the Pharmacokinetics of Statins}, volume = {42}, number = {8}, pages = {1301--1313}, year = {2014}, doi = {10.1124/dmd.114.057976}, publisher = {American Society for Pharmacology and Experimental Therapeutics}, abstract = {Organic anion transporting polypeptide (Oatp) 1a/1b knockout and OATP1B1 and -1B3 humanized mouse models are promising tools for studying the roles of these transporters in drug disposition. Detailed characterization of these models will help to better understand their utility for predicting clinical outcomes. To advance this approach, we carried out a comprehensive analysis of these mouse lines by evaluating the compensatory changes in mRNA expression, quantifying the amounts of OATP1B1 and -1B3 protein by liquid chromatography{\textendash}tandem mass spectrometry, and studying the active uptake in isolated hepatocytes and the pharmacokinetics of some prototypical substrates including statins. Major outcomes from these studies were 1) mostly moderate compensatory changes in only a few genes involved in drug metabolism and disposition, 2) a robust hepatic expression of OATP1B1 and -1B3 proteins in the respective humanized mouse models, and 3) functional activities of the human transporters in hepatocytes isolated from the humanized models with several substrates tested in vitro and with pravastatin in vivo. However, the expression of OATP1B1 and -1B3 in the humanized models did not significantly alter liver or plasma concentrations of rosuvastatin and pitavastatin compared with Oatp1a/1b knockout controls under the conditions used in our studies. Hence, although the humanized OATP1B1 and -1B3 mice showed in vitro and/or in vivo functional activity with some statins, further characterization of these models is required to define their potential use and limitations in the prediction of drug disposition and drug-drug interactions in humans.}, issn = {0090-9556}, URL = {https://dmd.aspetjournals.org/content/42/8/1301}, eprint = {https://dmd.aspetjournals.org/content/42/8/1301.full.pdf}, journal = {Drug Metabolism and Disposition} }